设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Elsevier电子期刊(21)
在“
Elsevier电子期刊
”中,
命中:
21
条,耗时:小于0.01 秒
在所有数据库中总计命中:
21
条
1.
A phase II study of preoperative
mFOLFOX6
with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis
作者:
Kyung Hwan Kim
a
;
1
;
Sang Joon Shin
b
;
1
;
Min Soo Cho
c
;
Joong Bae Ahn
b
;
Minkyu Jung
b
;
Tae Il Kim
d
;
Young Suk Park
e
;
Hoguen Kim
f
;
Nam Kyu Kim
c
;
NAMKYUK@yuhs.ac" class="auth_mail" title="E-mail the corresponding author
;
Woong Sub Koom
a
;
mdgold@yuhs.ac" class="auth_mail" title="E-mail the corresponding author
关键词:
Short-course radiotherapy
;
Rectal cancer
;
Metastasis
;
Chemotherapy
刊名:Radiotherapy and Oncology
出版年:2016
2.
Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study
作者:
M. Takatsuki
a
;
takatsuki@nagasaki-mc.com" class="auth_mail" title="E-mail the corresponding author
;
S. Tokunaga
b
;
S. Uchida
c
;
M. Sakoda
d
;
K. Shirabe
e
;
T. Beppu
f
;
Y. Emi
g
;
E. Oki
e
;
S. Ueno
h
;
S. Eguchi
a
;
Y. Akagi
i
;
Y. Ogata
c
;
H. Baba
j
;
S. Natsugoe
d
;
Y. Maehara
e
;
Kyushu Study Group of Clinical Cancer (KSCC)
关键词:
Liver metastasis
;
Colorectal cancer
;
Liver resection
;
mFOLFOX6
;
Bevacizumab
;
Conversion
;
Neoadjuvant chemotherapy
刊名:European Journal of Surgical Oncology (EJSO)
出版年:2016
3.
3:45 PMAbstract No. 8 - SIRFLOX: Differences in site of first progression between
mFOLFOX6
± bevacizumab (bev) versus mFOLFOX6 ± bev + selective internal radiation therapy (SIRT) in first-line patients (pts) with metastatic colorectal cancer (mCRC)
作者:
F. Moeslein
1
;
V. Heinemann
2
;
N. Sharma
3
;
M. Findlay
4
;
J. Ricke
5
;
R. Dowling
6
;
D. Price
7
;
V. Gebski
8
;
M. van Buskirk
9
;
P. Gibbs
10
;
G. van Hazel
11
刊名:Journal of Vascular and Interventional Radiology
出版年:2016
4.
Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
作者:
Shariq S. Khwaja
;
MD
;
PhD
&lowast
;
;
Amit Roy
;
BLA
&lowast
;
;
Stephanie Markovina
;
MD
;
PhD
&lowast
;
;
Todd A. Dewees
;
PhD
&lowast
;
;
Steven Hunt
;
MD
&dagger
;
;
Benjamin Tan
;
MD
&Dagger
;
;
Robert J. Myerson
;
MD
;
PhD
&lowast
;
;
Jeffrey R. Olsen
;
MD
&lowast
;
;
Parag J. Parikh
;
MD
&lowast
;
;
pparikh@radonc.wustl.edu" class="auth_mail" title="E-mail the corresponding author
刊名:International Journal of Radiation Oncology*Biology*Physics
出版年:2016
5.
2014 Final analysis of the PEAK trial: Overall survival (OS) and tumour responses during first-line treatment with
mFOLFOX6
+ either panitumumab (pmab) or bevacizumab (bev) in patients (pts) with metastatic colorectal carcinoma (mCRC)
作者:
F. Rivera
;
M. Karthaus
;
J.R. Hecht
;
G. Fasola
;
J.L. Canon
;
X. Guan
;
G. Demonty
;
L.S. Schwartzberg
刊名:European Journal of Cancer
出版年:2015
6.
2137 Comparison of two Phase II trials of
mFOLFOX6
plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver onl
刊名:European Journal of Cancer
出版年:2015
7.
2149 Impact of dose intensity in CAPOX and
mFOLFOX6
in the treatment of metastatic colorectal cancer
刊名:European Journal of Cancer
出版年:2015
8.
Personalized Dosing via Pharmacokinetic Monitoring of 5-Fluorouracil Might Reduce Toxicity in Early- or Late-Stage Colorectal Cancer Patients Treated With Infusional 5-Fluorouracil-Based Chemotherapy Regimens
作者:
Christina Leah B. Kline
1
;
Angelique Schiccitano
1
;
Junjia Zhu
2
;
Cheryl Beachler
1
;
Hassan Sheikh
1
;
Harold A. Harvey
1
;
Heath B. Mackley
1
;
3
;
Kevin McKenna
4
;
Kevin Staveley-O'Carroll
4
;
Lisa Poritz
4
;
Evangelos Messaris
4
;
David Stewart
4
;
Jeffrey Sivik
5
;
Wafik S. El-Deiry
1
;
weldeiry@hmc.psu.edu" class="auth_mail
关键词:
Chemotherapy
;
FOLFOX
;
5-FU
;
OnDose
;
Personalized cancer therapy
刊名:Clinical Colorectal Cancer
出版年:June 2014
9.
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial
作者:
Yasuhide Yamada
;
Daisuke Takahari
;
Hiroshi Matsumoto
;
Hideo Baba
;
Masato Nakamura
;
Kazuhiro Yoshida
;
Motoki Yoshida
;
Shigeyoshi Iwamoto
;
Ken Shimada
;
Yoshito Komatsu
;
Yasutsuna Sasaki
;
Taroh Satoh
;
Keiichi Takahashi
;
Hideyuki Mishima
;
Kei Muro
;
Masahiko Watanabe
;
Yuh Sakata
;
Satoshi Morita
;
Yasuhiro Shimada
;
Kenichi Sugihara
;
et al.
刊名:Lancet Oncology
出版年:December, 2013
10.
Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer
作者:
Johanna C. Bendell
;
Thomas J. Ervin
;
David Gallinson
;
Jaswinder Singh
;
James A. Wallace
;
Mansoor N. Saleh
;
Marcy Vallone
;
See-Chun Phan
;
Stephen P. Hack
关键词:
HGF/MET pathway
;
Metastatic colorectal cancer
;
Onartuzumab
;
Vascular endothelial growth factor (VEGF)
刊名:Clinical Colorectal Cancer
出版年:2013
1
2
3
按检索点细分(21)
题名(10)
关键词(3)
文摘(11)
按出版年细分(21)
2027年及以后(2)
2016年(4)
2015年(3)
2013年(1)
2012年(2)
2010年(3)
2009年(4)
2007年(1)
2006年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.